• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善介入放射学中的临床决策:用于预测经颈静脉肝内门体分流术后腹水改善情况的可解释机器学习模型

Improving Clinical Decisions in IR: Interpretable Machine Learning Models for Predicting Ascites Improvement after Transjugular Intrahepatic Portosystemic Shunt Procedures.

作者信息

İnce Okan, Önder Hakan, Gençtürk Mehmet, Golzarian Jafar, Young Shamar

机构信息

Department of Radiology, Rush University Medical College, Chicago, Illinois.

Department of Radiology, Health Sciences University, Prof Dr Cemil Tascioglu City Hospital, Istanbul, Turkey.

出版信息

J Vasc Interv Radiol. 2025 Jan;36(1):99-105.e1. doi: 10.1016/j.jvir.2024.09.022. Epub 2024 Oct 9.

DOI:10.1016/j.jvir.2024.09.022
PMID:39389232
Abstract

PURPOSE

To evaluate the potential of interpretable machine learning (ML) models to predict ascites improvement in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement for refractory ascites.

MATERIALS AND METHODS

In this retrospective study, 218 patients with refractory ascites who underwent TIPS placement were analyzed. Data on 29 demographic, clinical, and procedural features were collected. Ascites improvement was defined as reduction in the need of paracentesis by 50% or more at the 1-month follow-up. Univariate statistical analysis was performed. Data were split into train and test sets. Feature selection was performed using a wrapper-based sequential feature selection algorithm. Two ML models were built using support vector machine (SVM) and CatBoost algorithms. Shapley additive explanations values were calculated to assess interpretability of ML models. Performance metrics were calculated using the test set.

RESULTS

Refractory ascites improved in 168 (77%) patients. Higher sodium (Na; 136 mEq/L vs 134 mEq/L; P = .001) and albumin (2.91 g/dL vs 2.68 g/dL; P = .03) levels, lower creatinine levels (1.01 mg/dL vs 1.17 mg/dL; P = .04), and lower Model for End-stage Liver Disease (MELD) (13 vs 15; P = .01) and MELD-Na (15 vs 17.5, P = .002) scores were associated with significant improvement, whereas main portal vein puncture was associated with a lower improvement rate (P = .02). SVM and CatBoost models had accuracy ratios of 83% and 87%, with area under the curve values of 0.83 and 0.87, respectively. No statistically significant difference was found between performances of the models in DeLong test (P = .3).

CONCLUSIONS

ML models may have potential in patient selection for TIPS placement by predicting the improvement in refractory ascites.

摘要

目的

评估可解释机器学习(ML)模型预测经颈静脉肝内门体分流术(TIPS)治疗顽固性腹水患者腹水改善情况的潜力。

材料与方法

在这项回顾性研究中,分析了218例行TIPS治疗的顽固性腹水患者。收集了29项人口统计学、临床和手术特征数据。腹水改善定义为在1个月随访时腹腔穿刺需求减少50%或更多。进行单因素统计分析。数据分为训练集和测试集。使用基于包装器的顺序特征选择算法进行特征选择。使用支持向量机(SVM)和CatBoost算法构建两个ML模型。计算Shapley加法解释值以评估ML模型的可解释性。使用测试集计算性能指标。

结果

168例(77%)患者顽固性腹水得到改善。较高的钠(Na;136 mEq/L对134 mEq/L;P = .001)和白蛋白(2.91 g/dL对2.68 g/dL;P = .03)水平、较低的肌酐水平(1.01 mg/dL对1.17 mg/dL;P = .04)以及较低的终末期肝病模型(MELD)(13对15;P = .01)和MELD-Na(15对17.5,P = .002)评分与显著改善相关,而主要门静脉穿刺与较低的改善率相关(P = .02)。SVM和CatBoost模型的准确率分别为83%和87%,曲线下面积值分别为0.83和0.87。在DeLong检验中,模型性能之间未发现统计学显著差异(P = .3)。

结论

ML模型通过预测顽固性腹水的改善情况,可能在TIPS治疗患者选择方面具有潜力。

相似文献

1
Improving Clinical Decisions in IR: Interpretable Machine Learning Models for Predicting Ascites Improvement after Transjugular Intrahepatic Portosystemic Shunt Procedures.改善介入放射学中的临床决策:用于预测经颈静脉肝内门体分流术后腹水改善情况的可解释机器学习模型
J Vasc Interv Radiol. 2025 Jan;36(1):99-105.e1. doi: 10.1016/j.jvir.2024.09.022. Epub 2024 Oct 9.
2
Comparative Prognostic Utility of Updated Model for End-Stage Liver Disease Scores for Prediction of Early Mortality after Transjugular Intrahepatic Portosystemic Shunt Creation.终末期肝病评分更新模型对经颈静脉肝内门体分流术创建后早期死亡率预测的比较预后效用
J Vasc Interv Radiol. 2025 Jul;36(7):1125-1132.e6. doi: 10.1016/j.jvir.2025.03.023. Epub 2025 Apr 8.
3
The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.经颈静脉肝内门体分流术治疗肝硬化难治性腹水
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. doi: 10.1038/ncpgasthep0523.
4
TIPS versus paracentesis for cirrhotic patients with refractory ascites.经颈静脉肝内门体分流术与腹腔穿刺术治疗肝硬化难治性腹水的比较
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004889. doi: 10.1002/14651858.CD004889.pub2.
5
TIPS versus paracentesis for cirrhotic patients with refractory ascites.经颈静脉肝内门体分流术(TIPS)与腹腔穿刺术治疗肝硬化难治性腹水的比较
Cochrane Database Syst Rev. 2004(3):CD004889. doi: 10.1002/14651858.CD004889.
6
Development of machine learning model for predicting prolonged operation time in lumbar stenosis undergoing posterior lumbar interbody fusion: a multicenter study.用于预测接受后路腰椎椎间融合术的腰椎管狭窄症患者手术时间延长的机器学习模型的开发:一项多中心研究。
Spine J. 2025 Mar;25(3):460-473. doi: 10.1016/j.spinee.2024.10.001. Epub 2024 Oct 19.
7
Prediction of Insulin Resistance in Nondiabetic Population Using LightGBM and Cohort Validation of Its Clinical Value: Cross-Sectional and Retrospective Cohort Study.使用LightGBM预测非糖尿病人群的胰岛素抵抗及其临床价值的队列验证:横断面和回顾性队列研究
JMIR Med Inform. 2025 Jun 13;13:e72238. doi: 10.2196/72238.
8
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.肝硬化失代偿期食管静脉曲张出血患者的二级预防:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2.
9
Development of a machine learning model and a web application for predicting neurological outcome at hospital discharge in spinal cord injury patients.开发用于预测脊髓损伤患者出院时神经功能结局的机器学习模型和网络应用程序。
Spine J. 2025 Jan 31. doi: 10.1016/j.spinee.2025.01.005.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.